Lee Hong
la Jolla, CANPI 1144840646
Payments from drug & device makers
Across 87 payments — averaging $38.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$381
- Daiichi Sankyo Inc.$317
- Incyte Corporation$269
- Astellas Pharma US Inc$200
- Takeda Pharmaceuticals U.S.A., Inc.$163
- Genentech USA, Inc.$142
- plus $2K from 30 others
What the payments were for
- Food & beverage$2,62778%
- Education$72522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 4 | $381 |
| Daiichi Sankyo Inc. | 4 | $317 |
| Incyte Corporation | 4 | $269 |
| Astellas Pharma US Inc | 2 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $163 |
| Genentech USA, Inc. | 3 | $142 |
| Novartis | 6 | $131 |
| Foundation Medicine, Inc. | 1 | $119 |
| Johnson & Johnson | 4 | $105 |
| E.r. Squibb & Sons, L.L.C. | 1 | $105 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Seagen Inc. | 1 | $99 |
| Pfizer | 5 | $99 |
| AbbVie | 4 | $98 |
| AstraZeneca(2 entities) | 3 | $96 |
| Regeneron Healthcare Solutions, Inc. | 3 | $92 |
| Sobi, Inc | 4 | $90 |
| Eisai Inc. | 4 | $83 |
| ADC Therapeutics America, Inc. | 2 | $57 |
| Stemline Therapeutics Inc. | 2 | $55 |
| Rigel Pharmaceuticals, Inc. | 2 | $51 |
| Beigene USA, Inc. | 2 | $51 |
| Array Biopharma Inc | 2 | $51 |
| AVEO Pharmaceuticals, Inc. | 2 | $51 |
| Sanofi | 2 | $44 |
| Tersera Therapeutics LLC | 2 | $40 |
| Bayer | 2 | $32 |
| GSK | 1 | $30 |
| Deciphera Pharmaceuticals Inc. | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $29 |
| Exelixis Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $27 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Tempus AI, Inc | 1 | $20 |
| Accord Healthcare, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOUNDATIONONE LIQUID CDX$119
- LUMAKRAS$110
- Enhertu$102
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.